NCI Schedules 30 October 2026 Board Meeting to Approve Q3 and 9-Month Results

Bulletin Express10-20

New China Life Insurance Company Ltd. (NCI) has announced that its Board of Directors will convene on 30 October 2026 in Beijing to review and approve the group’s third-quarter financial statements for the nine months ended 30 September 2026. The meeting agenda also includes authorizing the public release of these results and addressing other corporate matters.

The notice, dated 20 October 2026, was signed by Chairman Yang Yucheng. Current board composition comprises one additional executive director (Gong Xingfeng), five non-executive directors (Yang Xue, Mao Sixue, Huang Geng, Hu Aimin, Zhang Xiaodong) and four independent non-executive directors (Xu Xu, Guo Yongqing, Zhuo Zhi, Sau Fun Susie Cheung).

Investors will gain insight into NCI’s year-to-date performance and third-quarter operating trends once the results are published following Board approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment